BioAge Labs to Present at Upcoming Investor Conferences

EMERYVILLE, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biopharmaceutical company developing therapeutic product candidates for cardiometabolic diseases by targeting the biology of human aging, today announced that the Company will participate in the following upcoming investor conferences: * Stifel NYC Healthcare Conference (New York, November 10–12, 2026): BJ Sullivan, PhD, Chief Strategy Officer, is scheduled to participate in a fireside chat on Thursday, November 12 from 1:20 PM to 1:50 PM EST. BJ Sullivan, Dov Goldstein, MD, CFO, and Alexis Jakubowski, Associate Director, Strategy & Investor Relations, will participate in one-on-one meetings. To access the live webcast of the presentation, register here. * UBS Global Biopharma Conference (London, November 16–17, 2026): BJ Sullivan, PhD, Chief Strategy Officer, is scheduled to participate in a fireside chat on Monday, November 16 from 11:40 AM to 12:10 PM EST. BJ Sullivan, Dov Goldstein, MD, CFO, and Alexis Jakubowski, Associate Director, Strategy & Investor Relations, will participate in one-on-one meetings. To access the live audio webcast of the presentation, register here. * Jefferies London Healthcare Conference (London, November 16–19, 2026): Kristen Fortney, PhD, CEO and co-founder, is scheduled to participate in a fireside chat on Thursday, November 19 from 6:00 AM to 6:25 AM EST. Kristen Fortney, Dov Goldstein, MD, CFO, BJ Sullivan, PhD, Chief Strategy Officer, and Alexis Jakubowski, Associate Director, Strategy & Investor Relations, will participate in one-on-one meetings. To access the live webcast of the presentation, register here. Replays of the presentations will be available in the investor section of the Company's website at https://ir.bioagelabs.com/, and will be archived for 30 days following the presentations.